Literature DB >> 16229821

Oct4 pseudogenes are transcribed in cancers.

Guangli Suo1, Jin Han, Xia Wang, Jingyu Zhang, Yannan Zhao, Yanhong Zhao, Jianwu Dai.   

Abstract

Octamer-binding transcription factor 4 (Oct4) plays a critical role for maintaining pluripotent and the self-renewing state of stem cells. Recent studies demonstrated that Oct4 gene was expressed in human cancers. Six pseudogenes of Oct4 have been proposed by using bioinformatics approach to analyze the genomic nucleotide sequences. Here, we reported that an Oct4 pseudogene localized in human chromosome 10 (Oct4-pg5) and a pseudogene in chromosome 8 (Oct4-pg1) were transcribed in cancer cell lines as well as cancer tissues tested, and they were not found transcribed in embryonic carcinoma cells, human fibroblasts, and normal tissues tested. Our results suggest that pseudogenes Oct4-pg5 and Oct4-pg1 may be involved in the regulation of Oct4 gene activity thus might be pertinent to carcinogenesis. Transcription of these Oct4 pseudogenes may have contributed artifacts to the current knowledge of Oct4 gene expression and function in cancers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16229821     DOI: 10.1016/j.bbrc.2005.09.157

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  78 in total

Review 1.  Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.

Authors:  Jennifer M Ryan; Allison R Pettit; Pascale V Guillot; Jerry K Y Chan; Nicholas M Fisk
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

2.  The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.

Authors:  Jiabo Di; Tjitske Duiveman-de Boer; Petra L M Zusterzeel; Carl G Figdor; Leon F A G Massuger; Ruurd Torensma
Journal:  Cell Oncol (Dordr)       Date:  2013-08-09       Impact factor: 6.730

3.  Genetic variants and prostate cancer risk: candidate replication and exploration of viral restriction genes.

Authors:  Joan P Breyer; Kate M McReynolds; Brian L Yaspan; Kevin M Bradley; William D Dupont; Jeffrey R Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

4.  Novel variants of Oct-3/4 gene expressed in mouse somatic cells.

Authors:  Nobuhiko Mizuno; Mitsuko Kosaka
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

5.  An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.

Authors:  Joan P Breyer; Daniel C Dorset; Travis A Clark; Kevin M Bradley; Tiina A Wahlfors; Kate M McReynolds; William H Maynard; Sam S Chang; Michael S Cookson; Joseph A Smith; Johanna Schleutker; William D Dupont; Jeffrey R Smith
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

6.  Oct4 expression is not required for mouse somatic stem cell self-renewal.

Authors:  Christopher J Lengner; Fernando D Camargo; Konrad Hochedlinger; G Grant Welstead; Samir Zaidi; Sumita Gokhale; Hans R Scholer; Alexey Tomilin; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

7.  Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.

Authors:  Paula Sotomayor; Alejandro Godoy; Gary J Smith; Wendy J Huss
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

8.  Human haematopoietic stem cells express Oct4 pseudogenes and lack the ability to initiate Oct4 promoter-driven gene expression.

Authors:  Zoe Redshaw; Alastair J Strain
Journal:  J Negat Results Biomed       Date:  2010-03-31

Review 9.  Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.

Authors:  Xia Wang; Jianwu Dai
Journal:  Stem Cells       Date:  2010-05       Impact factor: 6.277

10.  Association between an 8q24 locus and the risk of colorectal cancer in Japanese.

Authors:  Keitaro Matsuo; Takeshi Suzuki; Hidemi Ito; Satoyo Hosono; Takakazu Kawase; Miki Watanabe; Kohei Shitara; Koji Komori; Yukihide Kanemitsu; Takashi Hirai; Yasushi Yatabe; Hideo Tanaka; Kazuo Tajima
Journal:  BMC Cancer       Date:  2009-10-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.